Belongs to

• Solid Tumor Oncology Division

Types of Work

["2016"]

[[["Journal Articles",816],["Meeting Abstracts",613],["Book Sections",37],["Editorials",12],["Reviews",6],["Research Letters",3],["Books Whole",2],["Conference Papers",2],["Guidelines",2],["Miscellaneous",2]]]

[1495]

Popular keywords

• adult
• article
• controlled study
• female
• human
• immunotherapy
• ipilimumab
• melanoma
• nonhuman
• priority journal

Recent Works

1. TNF in the era of immune checkpoint inhibitors: Friend or foe?

   Review

   Chen, A. Y.; Wolchok, J. D.; Bass, A. R.
   Nature Reviews Rheumatology (2021)

   Fulltext@MSK | Save
2. A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma

   Journal Article

   Slingluff, C. L. Jr; Zarour, H. M.; Tawbi, H. A. H.; Kirkwood, J. M.; Postow, M. A.; Friedlander, P.; Devoe, C. E.; Gaughan, E. M.; Mauldin, I. S.; Olson, W. C. Jr; more...
   OncoImmunology (2021)

   Fulltext@MSK | Save
3. Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas

   Journal Article

   Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
   Clinical Cancer Research (2021)

   Fulltext@MSK | Save